YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Syncom Health
Syncom Health
BSE: 533157NSE: SYNCOMISIN: INE602K01014

3rd-Jul-2020 21:35Source: BSE

Syncom Healthcare - Intimation Pursuant To Regulation 7(2) Read With Regulations 6(2) Of Securities Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015

The Company has received intimation from Mr. Prateek Bankda (Promoter Group Shareholder of the Company) under Form C pursuant to Regulation 7(2) read with Regulations 6(2) of Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and all other applicable rules, if any on 03 July, 2020 intimating the sale of his shareholding through market.
Also, please find enclosed the personal disclosures received from Mr. Prateek Bankda, Promoter Group Shareholder of the Company, for disposal of shares dated 01 July, 2020
Kindly consider it as his personal disclosure pursuant to regulation 7(2) read with regulations 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 and all other applicable laws.

Please take the above information on record.